http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022112933-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8dc022ee08205af1515bda6b3ba5dc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf126bc99bba898cc7fb569d2eb819d3 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
filingDate | 2021-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e78daf0fc51291087551cd67c927db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8bbda24b6b6600e21c8b2c50bf95e38 |
publicationDate | 2022-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2022112933-A1 |
titleOfInvention | Diagnosis of chronic kidney disease (ckd) and its subgroups |
abstract | A method for diagnosing chronic kidney disease (CKD), including measuring an expression level of each microRNA (miRNA) of first miRNAs in a biological sample of a subject and comparing the expression level of each miRNA of the first miRNAs with a respective reference level corresponding to each miRNA of the first miRNAs. The first miRNAs may include miR-30a-5p (SEQ ID NO: 1), miR-486-5p (SEQ ID NO: 2), miR-29c-3p (SEQ ID NO: 3), and miR-200c-3p (SEQ ID NO: 4). Determining the CKD is responsive to higher expression levels of the miR-30a-5p (SEQ ID NO: 1) and the miR-486-5p (SEQ ID NO: 2) and lower expression levels of miR-29c-3p (SEQ ID NO: 3) and miR-200c-3p (SEQ ID NO: 4) than the respective reference level. |
priorityDate | 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.